IMURAN 50 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

imuran 50 mg

excella gmbh & co. kg - germania - azathioprinum - compr. film. - 50mg - imunosupresoare alte imunosupresoare

Clopidogrel ratiopharm Uniunea Europeană - română - EMA (European Medicines Agency)

clopidogrel ratiopharm

teva b.v. - clopidogrel (as hydrogen sulfate) - myocardial infarction; acute coronary syndrome; peripheral vascular diseases; stroke - agenți antitrombotici - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. pacienții adulți cu sindrom coronarian acut fără supradenivelare de segment st sindrom coronarian acut (angină pectorală instabilă sau non-q infarct miocardic), inclusiv pacienți supuși implantării de stent după intervenție coronariană percutanată în asociere cu acid acetilsalicilic (aas). supradenivelare de segment st infarct miocardic acut, în asociere cu aas în tratați medical, eligibili pentru tratamentul trombolitic. prevenirea aterotrombotice și tromboembolice în atrială fibrillationin pacienții adulți cu fibrilație atrială care au cel puțin un factor de risc de evenimente vasculare, nu sunt potrivite pentru tratamentul cu antagoniști ai vitaminei k (vka) și care au un nivel scăzut riscul de sângerare, clopidogrelul este indicat în asociere cu aas pentru prevenirea aterotrombotice și tromboembolice, inclusiv accident vascular cerebral.

DEXATOBROM 3 mg+1 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dexatobrom 3 mg+1 mg/ml

rompharm company s.r.l. - romania - combinatii (tobramycinum+dexamethasonum) - pic. oft., susp. - 3mg+1mg/ml - antiinflamatoare si antiinfectioase in combinatie corticosteroizi si antiinfectioase in combinatie

SOLUTIE CONTRA AFTELOR BUCALE 2,425 mg/21,34 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

solutie contra aftelor bucale 2,425 mg/21,34 mg/ml

meduman s.a. - romania - combinatii - pic. bucofaringiene sol. - 2,425mg/21,34mg/ml - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

ESPUMISAN 100 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

espumisan 100 mg/ml

berlin-chemie ag (menarini group) - germania - simethiconum - pic. orale, emulsie - 100mg/ml - med. pt.trat.tulburarilor functionale gastro-intestinale alte medicamente pt.tulb. intestinale functionale

ESPUMISAN  L 40mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

espumisan l 40mg/ml

berlin-chemie ag - germania - simethiconum - pic. orale, emulsie - 40mg/ml - med. pt.tulburari intestinale functionale alte medicamente pt.tulb. intestinale functionale